NYSE:HIMS Hims & Hers Health (HIMS) Stock Price, News & Analysis $21.80 -1.73 (-7.35%) (As of 11/20/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About Hims & Hers Health Stock (NYSE:HIMS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Hims & Hers Health alerts:Sign Up Key Stats Today's Range$21.44▼$23.1250-Day Range$15.82▼$27.8952-Week Range$7.51▼$30.44Volume18.37 million shsAverage Volume21.45 million shsMarket Capitalization$4.76 billionP/E Ratio49.55Dividend YieldN/APrice Target$20.71Consensus RatingHold Company OverviewHims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.Read More… This company will win the AI race (Ad)Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry. Hims & Hers Health Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks71st Percentile Overall ScoreHIMS MarketRank™: Hims & Hers Health scored higher than 71% of companies evaluated by MarketBeat, and ranked 303rd out of 963 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.2 / 5Analyst RatingHold Consensus RatingHims & Hers Health has received a consensus rating of Hold. The company's average rating score is 2.38, and is based on 7 buy ratings, 8 hold ratings, and 1 sell rating.Amount of Analyst CoverageHims & Hers Health has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Hims & Hers Health's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth72.41% Earnings GrowthEarnings for Hims & Hers Health are expected to grow by 72.41% in the coming year, from $0.29 to $0.50 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Hims & Hers Health is 49.55, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 124.79.Price to Earnings Ratio vs. SectorThe P/E ratio of Hims & Hers Health is 49.55, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 89.02.Price to Book Value per Share RatioHims & Hers Health has a P/B Ratio of 10.85. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Hims & Hers Health's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted19.10% of the float of Hims & Hers Health has been sold short.Short Interest Ratio / Days to CoverHims & Hers Health has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Hims & Hers Health has recently increased by 6.18%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldHims & Hers Health does not currently pay a dividend.Dividend GrowthHims & Hers Health does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted19.10% of the float of Hims & Hers Health has been sold short.Short Interest Ratio / Days to CoverHims & Hers Health has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Hims & Hers Health has recently increased by 6.18%, indicating that investor sentiment is decreasing significantly. News and Social Media2.9 / 5News Sentiment0.26 News SentimentHims & Hers Health has a news sentiment score of 0.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.46 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 33 news articles for Hims & Hers Health this week, compared to 13 articles on an average week.Search Interest128 people have searched for HIMS on MarketBeat in the last 30 days. This is an increase of 125% compared to the previous 30 days.MarketBeat Follows32 people have added Hims & Hers Health to their MarketBeat watchlist in the last 30 days. This is an increase of 14% compared to the previous 30 days. Company Ownership4.2 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Hims & Hers Health insiders have sold 16,157.13% more of their company's stock than they have bought. Specifically, they have bought $132,260.00 in company stock and sold $21,501,682.00 in company stock.Percentage Held by Insiders17.71% of the stock of Hims & Hers Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions63.52% of the stock of Hims & Hers Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Hims & Hers Health's insider trading history. Receive HIMS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hims & Hers Health and its competitors with MarketBeat's FREE daily newsletter. Email Address HIMS Stock News HeadlinesHims & Hers Health, Inc. (NYSE:HIMS) COO Melissa Baird Sells 58,750 SharesNovember 20 at 5:31 AM | insidertrades.comAnja Manuel Purchases 1,000 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) StockNovember 15, 2024 | insidertrades.comI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. November 21, 2024 | Porter & Company (Ad)3 Top Stocks Crushing Q3 Earnings With Strong 2024 GuidanceHims & Hers, Payoneer, and Astera Labs lead Q3 earnings with standout revenue growth, forecast upgrades, and strategic wins—stocks to watch for growth potentialNovember 12, 2024 | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) Insider Patrick Harrison Carroll Sells 15,000 SharesNovember 8, 2024 | insidertrades.comMelissa Baird Sells 58,750 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) StockNovember 21 at 4:27 AM | americanbankingnews.comHims & Hers Stock Climbs After Former Regulator Autor Joins BoardNovember 18 at 5:51 PM | marketwatch.comHims & Hers names Deb Autor to board, Janet Stevens as head of quality, safetyNovember 18 at 12:48 PM | markets.businessinsider.comSee More Headlines HIMS Stock Analysis - Frequently Asked Questions How have HIMS shares performed this year? Hims & Hers Health's stock was trading at $8.90 at the beginning of 2024. Since then, HIMS shares have increased by 144.9% and is now trading at $21.80. View the best growth stocks for 2024 here. How were Hims & Hers Health's earnings last quarter? Hims & Hers Health, Inc. (NYSE:HIMS) posted its quarterly earnings data on Monday, November, 4th. The company reported $0.32 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.06 by $0.26. The business's quarterly revenue was up 77.1% on a year-over-year basis. Who are Hims & Hers Health's major shareholders? Hims & Hers Health's top institutional investors include State Street Corp (2.15%), Geode Capital Management LLC (2.00%), Wellington Management Group LLP (1.60%) and Connor Clark & Lunn Investment Management Ltd. (0.79%). Insiders that own company stock include Melissa Baird, David B Wells, Alex Bard, Patrick Harrison Carroll, Michael Chi, Soleil Boughton, Jules A Maltz, Oluyemi Okupe, Christopher D Payne, Andrew Dudum, Christiane Pendarvis, Irene Becklund, Anja Manuel, Lynne Chou O'keefe and Jack Abraham. View institutional ownership trends. How do I buy shares of Hims & Hers Health? Shares of HIMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Hims & Hers Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Hims & Hers Health investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Palantir Technologies (PLTR), Netflix (NFLX) and Palo Alto Networks (PANW). Company Calendar Last Earnings11/04/2024Today11/21/2024Fiscal Year End12/31/2024Next Earnings (Estimated)2/24/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Offices & clinics of medical doctors Sub-IndustryHealthcare Current SymbolNYSE:HIMS CUSIPN/A CIK1773751 Webwww.forhims.com Phone415-851-0195FaxN/AEmployees1,046Year FoundedN/APrice Target and Rating Average Stock Price Target$20.71 High Stock Price Target$28.00 Low Stock Price Target$10.00 Potential Upside/Downside-5.0%Consensus RatingHold Rating Score (0-4)2.38 Research Coverage16 Analysts Profitability EPS (Most Recent Fiscal Year)$0.44 Trailing P/E Ratio49.55 Forward P/E Ratio75.17 P/E GrowthN/ANet Income$-23,550,000.00 Net Margins8.19% Pretax Margin4.16% Return on Equity10.97% Return on Assets8.29% Debt Debt-to-Equity RatioN/A Current Ratio2.14 Quick Ratio1.82 Sales & Book Value Annual Sales$1.24 billion Price / Sales3.83 Cash FlowN/A Price / Cash FlowN/A Book Value$1.61 per share Price / Book13.54Miscellaneous Outstanding Shares218,479,000Free Float179,786,000Market Cap$4.76 billion OptionableOptionable Beta1.06 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report This page (NYSE:HIMS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.